- Home
- OSW vs QURE Comparison
OSW vs QURE Comparison
Compare OSW & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSW | QURE |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | Bahamas | Netherlands |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | OSW | QURE |
|---|---|---|
| Price | $20.56 | $24.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | $23.67 | ★ $56.25 |
| AVG Volume (30 Days) | 642.6K | ★ 2.1M |
| Earning Date | 02-18-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.00% | N/A |
| EPS Growth | ★ 40.79 | N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $936,080,000.00 | $15,751,000.00 |
| Revenue This Year | $8.65 | N/A |
| Revenue Next Year | $7.26 | $142.93 |
| P/E Ratio | $28.68 | ★ N/A |
| Revenue Growth | ★ 7.27 | N/A |
| 52 Week Low | $14.21 | $7.76 |
| 52 Week High | $23.49 | $71.50 |
Technical Indicators
Market Signals| Indicator | OSW | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 50.48 |
| Support Level | $19.23 | $22.32 |
| Resistance Level | $20.40 | $28.48 |
| Average True Range (ATR) | 0.75 | 1.83 |
| MACD | 0.05 | 0.42 |
| Stochastic Oscillator | 45.18 | 41.37 |
Price Performance
Historical ComparisonAbout OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.